Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EPI-MINN: Targeting Cognition and Motivation - National

NCT: NCT05877716 · ACTIVE_NOT_RECRUITING

NCT IDNCT05877716
StatusACTIVE_NOT_RECRUITING
Start Date2023-05-30
Completion2027-03-31
SponsorUniversity of Minnesota (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. We will recruit participants who are receiving care for early psychosis from clinics across the United States. We will compare outcomes from participants who receive treatment at coordinated specialty care (CSC) early psychosis clinics to those that receive standard community care. A qualifying CSC program will provide comprehensive clinical services such as psychotherapy, medication management, psychoeducation, and work or education support. This study will be conducted remotely, and participants can participate at home with their own electronic devices. The aim of this study is to investigate a well-defined 12-week mobile intervention program specifically designed to target cognitive functioning and motivated behavior for individuals with early psychosis. Participants will complete a screening interview which will include diagnosis and symptom ratings, neurocognitive assessment, and self-reports of symptoms, behavior, and functioning. Then participants will be randomized to receive the 12-week mobile intervention, or an active control of treatment as usual. The investigators will test for differences in the clinical trajectories after training, and at two follow up appointments at 6 and 12 months post-training.

Frequently Asked Questions

What is EPI-MINN: Targeting Cognition and Motivation - National?

EPI-MINN: Targeting Cognition and Motivation - National is a clinical trial registered under NCT05877716. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05877716?

The current status of NCT05877716 (EPI-MINN: Targeting Cognition and Motivation - National) is: ACTIVE_NOT_RECRUITING.

When did EPI-MINN: Targeting Cognition and Motivation - National start?

EPI-MINN: Targeting Cognition and Motivation - National started on 2023-05-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.